First IPO In Germany In 2005 - Paion Listed On The Frankfurt Stock Exchange (FWB)

Paion AG went public in the Prime Standard of the Frankfurt Stock Exchange (FWB) on Friday. The announcement was made by Deutsche Börse AG, as operator of the FWB. Paion’s shares were initially priced at €8. Lead manager and bookrunner of the issue was UBS Investment Bank, Co-Lead-Manager Dresdner Kleinwort Wasserstein and Co-Manager Landesbank Baden-Württemberg. The initial price was determined on Xetra, the pan-European trading platform.

Together with Paion, 41 pharmaceutical and healthcare companies with a market capitalization of around €25 billion are now listed on the Prime Standard of the Frankfurt Stock Exchange; including Paion, this includes 15 biotechnology companies, seven healthcare companies, twelve medical technology companies and seven pharmaceutical companies.

According to Paion, the biopharmaceutical company based in Aachen, aims to become a leading provider of innovative drugs for treatment of stroke and other thrombotic diseases. Since its foundation in 2000, Paion has raised approximately €51 million in four equity financing rounds.

Issuers can choose between two clearly defined segments for the admission of their shares to the FWB: Prime Standard and General Standard. Companies listed in Prime Standard have to meet international transparency requirements. This segment is tailored to the needs of companies that wish to attract global investors. The statutory transparency requirements apply in General Standard. This segment is suited to companies that primarily target domestic investors and prefer a less costly listing. There are currently around 350 companies listed in Prime Standard and around 470 in General Standard.